Francisco Javier Leiva

Dr. Francisco Javier Leiva


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Genomics
Verified
Journal Article
Closed access
FLFrancisco Javier Leiva
Francisco Javier Leiva
MHMarcelo Rojas Herrera
Marcelo Rojas Herrera
DRDaniela Reyes
Daniela Reyes
SBScarleth Bravo
Scarleth Bravo
KGKillen Garcia
Killen Garcia
Rodrigo VidalRodrigo Vidal
Rodrigo Vidal



17 June 2019 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
KGKillen Garcia
Killen Garcia
JTJorge Touma
Jorge Touma
SBScarleth Bravo
Scarleth Bravo
FLFrancisco Javier Leiva
Francisco Javier Leiva
LVLuis Vargas-Chacoff
Luis Vargas-Chacoff
Rodrigo VidalRodrigo Vidal
Rodrigo Vidal

16 November 2023 in Heliyon
Verified
Journal Article
Open access
SBScarleth Bravo
Scarleth Bravo
JMJavier Moya
Javier Moya
FLFrancisco Javier Leiva
Francisco Javier Leiva
OGOsiel Guzman
Osiel Guzman
Rodrigo VidalRodrigo Vidal
Rodrigo Vidal
In the Chilean salmon farming industry, infection by Piscirickettsia salmonis is the primary cause of the main bacterial disease known as Piscirickettsiosis, which has an overwhelming economic impact. Although it has been demonstrated that Piscirickettsiosis modifies the expression of numerous salmonids genes, it is yet unknown how alternative splicing (AS) contributes to salmonids bacterial infection. AS, has the potential to create heterogeneity at the protein and RNA levels and has been associated as a relevant molecular mechanism in the immune response of eukaryotes to several diseases. In this study, we used RNA data to survey P. salmonis-induced modifications in the AS of Atlantic salmon and found that P. salmonis infection promoted a substantial number (158,668) of AS events. Differentially spliced genes (DSG) sensitive to Piscirickettsiosis were predominantly enriched in genes involved in RNA processing, splicing and spliceosome processes (e.g., hnRNPm, hnRPc, SRSF7, SRSF45), whereas among the DSG of resistant and susceptible to Piscirickettsiosis, several metabolic and immune processes were found, most notably associated to the regulation of GTPase, lysosome and telomere organization-maintenance. Furthermore, we found that DSG were mostly not differentially expressed (5–7 %) and were implicated in distinct biological pathways. Therefore, our results underpin AS achieving a significant regulatory performance in the response of salmonids to Piscirickettsiosis.

1 April 2026 in Life
Verified
Journal Article
Open access
PDF file
FLFrancisco Javier Leiva
Francisco Javier Leiva
LCLuis Constandil
Luis Constandil
Pedro Chaná-CuevasPedro Chaná-Cuevas
Pedro Chaná-Cuevas
RVRene Vidal
Rene Vidal
BMBernardo Morales
Bernardo Morales
Rodrigo VidalRodrigo Vidal
Rodrigo Vidal
Idiopathic Parkinson’s disease (iPD) represents the most prevalent form of Parkinson’s disease; however, the molecular mechanisms underlying its development remain only partially understood. N6-methyladenosine (m6A), the most abundant internal RNA modification in eukaryotic mRNA, has emerged as a key regulator of gene expression and has been implicated in neurodegenerative disorders. In this study, we performed integrated differential expression, weighted gene co-expression network analysis (WGCNA), and differential co-expression (DECO) analyses using peripheral blood RNA-seq data from Latin American controls and early iPD patients to investigate m6A-associated transcriptional alterations. WGCNA and differential expression analyses identified 1207 hub genes and 237 differentially expressed genes, respectively. The integration of these datasets with curated m6A-related genes yielded 12 overlapping candidate genes associated with early iPD. Subsequent DECO analysis revealed three significant m6A regulator–target differential co-expression links involving the m6A factors VIRMA, YTHDF3, and HNRNPA2B1. Experimental validation in an independent exploratory cohort confirmed altered expression of these regulators and increased m6A enrichment of NRCAM and PKHD1 transcripts. To our knowledge, this study represents the first integrative transcriptomic evaluation of m6A-associated regulatory patterns in early iPD within a Latin American population. Collectively, our findings suggest that selective m6A-associated transcriptional network alterations may contribute to the systemic molecular signatures observed in early iPD, warranting further validation in larger and mechanistically oriented studies.